Site Map

Blood stem cells diversify earlier than thought

Essential Haematology Day

Member login

New AML genes discovered

2017 Clinical Excellence Awards Round

Applications open to become the next BSH Student Representative

Participate in the national Blood Transfusion and Blood Donation Survey

RCP publish Future Hospital Programme report

Applications invited for the position of Editor-in-Chief British Journal of Haematology

Register now and save up to £150

Abstract submissions for the BSH Annual Scientific Meeting 2018

A HaemSTAR is born

Survey reveals current UK practice of managing Hodgkin’s lymphoma in older patients

Applications open for L'Oreal-UNESCO Women in Science Awards

Digital digest

Ibrutinib non-responders may benefit from combination therapy for CLL

Digital digest - 2 February

HSF1 blockers promising for multiple myeloma

DNA repair and packaging genes linked to multiple myeloma risk

BSH Blood Transfusion Guidelines used in NBTC Blood Components App

Digital digest - 9 February

Ageing immune system ‘key to cancer development risk’

Hybrid-capture sequencing backed for lymphoid cancer

Digital digest - 16 February

Latest radiotherapy device will fine-tune bone marrow irradiation

BSH member Dr Amit Sud awarded haematology research medal

Progress predicted in haemoglobin disorder care

Landmark CAR T-cell study results published

Warning over anticoagulant use for atrial fibrillation in CKD

Digital digest - 23 February

Imaging tools reveals inner structure of red blood cells

Celebrating Success: BSH member part of haematology department awarded Myeloma UK service award

Promise for novel treatment in severe bleeding disorder

Digital Digest - 2 March

Age does not affect NHL survival after HCT

STAT5 inhibitor could target oncogenic pathway in leukaemia

Increased heart failure risk for breast cancer and lymphoma patients

Mixed-phenotype acute leukaemia patients benefit from less toxic therapy

International women's day 2018: Meet some of our women members making a difference in haematology

Digital Digest - 20 April

Former BSH President Allan Victor Hoffbrand wins Sultan Bin Khalifa International Thalassemia Grand International Award

Cardiovascular risks faced by child cancer survivors

Clue to future ALL relapse

Headway in development of lymphoma epigenetics therapeutics

BSH becomes sponsor and partner of Health Volunteers Overseas

Stored blood ‘less safe’ for some patients

Warning as blood stocks stay low

BSH announces Professor Simon Rule as new Vice President

Scientists get stem cells through... the snow

Rare disease patients need Europe - MPs

Applications are now open for NHS England’s Clinical Entrepreneurs Programme

New therapeutic targets for aggressive diffuse large B-cell lymphoma

Warfarin alternatives effective for catheter ablation

Anaemia risks maternal death

Applications open for Chief Scientific Officer's Knowledge Transfer Partnership programme for leaders in healthcare science

Annual Scientific Meeting - Join the social media campaign

New VTE prevention guidance for over-16s

Professor John Barrett MD appointed as Editor-in-Chief of British Journal of Haematology

Genetic variation and biomarkers may help predict brain injury risk in paediatric ALL

Gene fusion an early event in childhood leukaemia

Chronic graft-versus-host disease gene regulation insight

‘Organic gene therapy’ approach suggested for red cell disorders

New cancer drug class unveiled at Imperial

Genetic alterations in multiple myeloma revealed

Novel epigenetic link to blood cancer

NHS genomics project “at risk” - MPs

BSH announces Professor Cheng-Hock Toh as President

Special Resolution to adopt updated articles

Digital Digest - 11 May

Bloodwise Highlights from the BSH Annual Scientific Meeting 2018

NHS preparing to offer CAR-T therapy to patients

‘Young, Black and Stigmatised’ - Dr Sonia Wolf wins inaugural Crucible Prize

Progress towards universal red cell source

Meta-analysis reveals best treatments for post-partum haemorrhage

The Aplastic Anaemia Trust are inviting grant applications as they launch new research strategy

Genetic profiling of blood samples could help personalise multiple myeloma treatment

Genomic analysis could help patients with DLBCL

Type O blood ‘increases risk of death from trauma’

World Thalassaemia Day – Time of new hope?

BSH celebrating International Nurses Day 2018

Introducing Professor Cheng-Hock Toh - BSH President's first message

Step towards biomarker that predicts CAR T cell therapy response

Senior haematologists have called on NHS England to reverse restrictions on using ibrutinib to treat relapsed chronic lymphocytic leukaemia

CPD budget cuts affecting nursing skills - Royal College of Nursing

Tablet hope for cancer-related VTE

Genome sequencing allows improved blood transfusion matching

Inflammatory signalling protein plays key role in AML

Haemophilia survey highlights fears

ALL gene-environment interaction points to hygiene factor

How haemophilia nursing care is evolving

European trial of new leukaemia drug pairing

Reprogrammed cells could correct haemophilia B

Genomic atlas of human plasma proteome unveiled

BSH celebrate World Blood Donor Day 2018

Chief Executive of the Sickle Cell Society is awarded an OBE in the Queen’s Birthday Honours.

Bone marrow recreated in lab

Gene editing of healthy cells offers prospect for CAR T treatment of AML

World Sickle Cell Day - Dr Sonia Wolf Q&A

What is Sickle Cell Disease (SCD)?

Football key to blood donor recruitment

New target to fight Fanconi anaemia

GP urgent cancer referrals increase sharply

Message from BSH President

Lymphoma risk from myelofibrosis treatment

Blood cancer therapy toxicity examined

New drugs are improving survival times for patients with aggressive type of blood cancer

BSH Celebrating 70 years of the NHS

Sepsis research targets vascular leakage

New drugs improve MCL patient survival times

Leukaemia virus changes DNA packaging

DOACs a safe alternative to warfarin

EMA approves CAR T-cell therapies in milestone decision

Former BSH President Dr Patrick Carrington interviewed on BBC 5 Live for NHS 70th Anniversary

Contaminated blood inquiry truth promise

Gene therapy hope for Hunter syndrome

Genetic changes in blood predict AML risk

Biomedical science day 2018 - Meet BSH Member Dr Maria Teresa Esposito

AML cell study offers clues to super-drug improvement

Off-target effects dash gene editing hopes

Genetics of Xga blood group system uncovered

Urine test useful for monoclonal gammopathy

A message from BSH President, Professor Cheng-Hock Toh

BSH President Professor Cheng-Hock Toh elected as Academic Vice President of the RCP

Blood cancers taking longer to be diagnosed than other cancers

Study informs on monosomy 7 genetics

Fertility risk for sickle cell and chemotherapy patients

Knife crime surge draws on blood stocks

Urgent appeal for Ro blood donors

BSH expanding Early Stage Research Start-Up programme

Leukaemia patients spared repeat chemotherapy following NHS review

Shot Report 2017 published

Obituary - Dr S. Mitchell Lewis

Former BSH President Dr Victor Hoffbrand receives Wallace H. Coulter Award for Lifetime Achievement in Haematology

Computational platform developed for multiple myeloma treatment

Simple blood test could detect Multiple Myeloma

Novel targets for mixed lineage leukaemia

Patients perplexed by blood cancer diagnosis

Brexit blood product plans revealed

Tributes to campaigner who became nurse

Blood cancer patients could be denied life-saving CAR-T therapy

A message from BSH President, Professor Cheng-Hock Toh - August 2018

Blood cancer awareness - Meet BSH Member Graham Collins

Celebrating NHS 70 and Haematology

Blood test predicts lymphoma therapy success

Enzymes may enable type O blood transformation

CAR-T backed for NHS

“Achilles’ heel” of anaplastic large-cell lymphoma identified

Study discovers ten times more haematopoietic stem cells than previously thought

Study reveals the impact on the brain of chemotherapy for acute lymphoblastic leukaemia

Comment: Dr Maria Esposito on NHS decision to approve use of CAR T therapy

AI to improve platelet supply

Genomics focus: Meet BSH Member David Rees

European collaboration for cancer research

CAR-T therapy provisionally rejected for adult B-cell lymphoma

Office Closure & Temporary Office Move

ASM 2019: Call for abstract reviewers

Changes to BSH Membership from 2019

Immediate compression may reduce risk of long-term DVT complications

A message from BSH President, Professor Cheng-Hock Toh - September 2018

Paediatric radiotherapy guidance updated for new technologies

Lung cancer drugs studied for leukaemia treatment

BSH Student Essay Prize 2018

Inquiry searches for undiagnosed blood contamination victims

Apply for the 2019 Healthcare Science Awards

Dan's Story: BSH member inspires patient to follow career in medicine

CAR-T deal allows adult lymphoma treatment

May’s SOS for cancer care

Leukaemia UK launch 'Future of Haematology' Grants Programme

Hope for fewer blood transfusions for myelodysplasia care

World Thrombosis Day 2018 - Message from BSH President Professor Cheng-Hock Toh

World Thrombosis Day: Meet BSH Member & Thrombosis expert Professor Beverley Hunt

World Thrombosis Day: Thrombosis UK offer range of resources, grants and educational opportunities

New prognostic tool provides “step change” in myeloproliferative neoplasm care

Blood and organ donors from black communities needed

Genetics-based prognostic tool developed for myelodysplastic syndrome

NIHR-BSH Researcher of the Year Award scheme 2019

Massive new AML dataset published

BSH & Wiley renew partnership to publish British Journal of Haematology

New technique revealed to help blood cells regenerate

A message from BSH President, Professor Cheng-Hock Toh - October 2018

Duvelisib hope for hard-to-treat CLL and SLL

BSH Crucible Prize: Feature with 2018 winner Dr Sonia Wolf

‘Rethink’ needed for classification of VTE

Relapsed AML returns in ‘stealth mode’

National Pathology Week - Meet BSH Member Dr Sheila O'Connor

Low-fat diet might benefit obese children with ALL

Denosumab effective for osteoporosis in transfusion-dependent thalassaemia

Chemotherapy and immunotherapy success in AML study

Top 10 research priorities for living with and beyond cancer announced

AML gene study brings personalised medicine one step closer

Discount deal makes CAR-T available to young leukaemia patients

Multiple myeloma drug hope

A message from BSH President, Professor Cheng-Hock Toh - November 2018

‘Universal plasma’ filtration plans unveiled

SCID study identifies factors influencing survival

BSH to offer EHA Travel Grants

CRISPR therapy feasible for foetal haemoglobin reactivation

BSH Communications Committee Vacancy

Fred Hutchinson researchers present latest on CAR-T cell therapy at ASH 2018

Chance discovery could revolutionise platelet donations

Paediatric CAR-T therapy begins in England

BSH President Professor Cheng Hock Toh pays tribute to outgoing Editor of BJHaem, Professor Finbarr Cotter

Sickle cell gene therapy success

New tool to identify aggressive lymphomas

Differences between paediatric and adult AML uncovered

CAR T-cell therapy approved for more NHS treatment

CRISPR accuracy breakthrough

A message from BSH President, Professor Cheng-Hock Toh - December 2018

Obituary - Professor Sir David Weatherall

Lenalidomide extends remission in newly-diagnosed myeloma

Eye drop treatment offers AML hope

Human skin cells turned into blood stem cells

First European CAR T cell meeting announced

Boosted cord blood aids transplant

Haematology Nursing: Meet BSH Member Bethan Ingram

AZD8055 promise for CLL combination treatment

Comments needed for ASH VTE Guideline Treatment of Acute VTE

NHS plan offers new hope for blood cancer care

Blood screening for Zika ‘not cost‑effective’

CRISPR gene editing library identifies new immune regulators

Infected Blood Inquiry

Venetoclax fast-tracked into NHS for CLL

Ibrutinib effective for CLL therapy

New genetic classification of B-ALL

‘Twin genes’ behind B-cell disease are not identical

World Thrombosis Day Campaign Appoints BSH member Beverley Hunt as New Steering Committee Chair

A message from BSH President, Professor Cheng-Hock Toh - January 2019

Delays in blood cancer diagnosis could be avoided, Yorkshire study finds

No benefit from transplantation in hypodiploid ALL for children and young people, study finds

Leukaemia causes bone marrow cells to age prematurely

NICE recommends new CAR-T cell therapy for DLBCL

BSH grant recipient has work published in Oncogene

Tissue homing of T cells revealed

Hope for new drugs for relapsed AML

CAR‑T therapy rejected for DLBCL in Scotland

Antibody could prepare for stem cell transplant

Sickle cell silent strokes studied

Obituary - Dr Bryon Roberts (1933 - 2019)

Vitamin D and immune cells stimulate myelofibrosis in MPN

BSH gathering UK Clinical Haematology Workforce data

BSH partnering with HVO to offer short term overseas placements for UK Haematologists

BSH and Wiley partner on a peer-reviewed open access journal

A message from BSH President, Professor Cheng-Hock Toh - February 2019

‘Invisible’ stem cells offer new transplant prospects

Roger Counter Foundation to support BSH Research Grants

Role of free radicals in blood clotting revealed

Patient involvement partnership sets priorities for rare inherited anaemias

Thromboprophylaxis study shows limited benefits for cancer patients

Telomere test for CLL

International women's day 2019: Meet some of our women members making a difference in haematology

Second patient achieves full HIV remission after stem cell therapy

Vitamin analogue may boost stem cell transplant

AML cell type atlas created

Daratumumab combination therapy approved for relapsed multiple myeloma

Half-matched transplant success for sickle cell and thalassaemia

Two-minute test to assess platelet function developed

BSH Ordinary Trustee election results

Contradictory role for protein in AML uncovered

BSH Annual Scientific Meeting 2019 - Join the social media campaign

A message from BSH President, Professor Cheng-Hock Toh - March 2019

Chronic oncologist shortages revealed

New study reveals how mistakes in antibody production may trigger ALL

General Haem Task Force Vacancy

Deformable blood stem cells could help transplant procedures

Drug combination gives hope to older AML patients

Surprising role for protein in GvHD

Live imaging shows CAR-T therapy killing lymphoma cells

New sub groups of acute erythroid leukaemia defined

Gilteritinib improves FLT3-mutated AML survival

Successful gene therapy for SCID in infants

Cancer genetic vulnerabilities revealed on a large scale using CAS-9 knock out screens

Prophylactic Factor VIIa therapy tested for haemophilia

Old diabetes drug shows promise for preventing lymphoma

Professor Victor Hoffbrand receives BSH Lifetime Achievement Award

New promising target for AML discovered

Gene therapy may outperform stem cell transplant for beta-thalassaemia

Grant Impact report: Dr Yeong Jer Lim, ASH Travel Scholarship, 2018

High-risk multiple myeloma DNA marker identified

Grant Impact report: Dr George Adams, ASH Travel Scholarship, 2018

New study paves the way for B cell therapy

Single-cell analysis of bone marrow microenvironment cells completed

Spliceosome could hold key to stopping AML progression

‘Powerful’ APL drug combination could benefit AML patients

New drug can tackle ibrutinib resistance in MCL patients

Experts call for SCD screening for migrants in Europe

New molecule driving Hodgkin’s lymphoma growth discovered

Grant Impact report: Katie Parrott, Student Elective Scholarship 2018

Genetic variations may affect sickle cell trait athletes’ risk of collapse

Meet Huw Rowswell - NIHR / BSH Nursing Award Winner

Lenolidomide approved by NICE for treatment of multiple myeloma

A message from BSH President, Professor Cheng-Hock Toh - May 2019

Neurotoxic side-effects of CAR T-cell therapy revealed

Wnt signalling study brings lab-made stem cells closer

New culture technique could increase access to stem cell transplants

New target for B-cell lymphoma identified

'Antimicrobial resistance: Biting the hand that feeds' - Dr Jennifer Darlow wins Crucible Prize

New avenue for targeted therapy for T-cell leukaemia

Measuring walking speed aids prognosis of elderly cancer patients

Triple therapy boosts B-cell lymphoma treatment

New haemophilia gene therapy to help young patients

Grant Impact report: Thea Chandler, Student Elective Scholarship 2018

Grant Impact report: Eilish McKenna, Student Elective Scholarship 2018

Sickle Cell Disease in Childhood: Standards for Clinical Care Consultation

Pregnancy history of blood donors does not affect recipient mortality risk

World Sickle Cell Day 2019 - Dr Banu Kaya explains the advances made in the understanding and treatment of SCD

Hope for non-invasive prenatal sickle test

AML researcher receives Cancer Research UK fellowship grant

NHS prepares for new generation of ‘agnostic’ cancer drugs

Promising early results for novel sickle cell drug

BSH Global Haem SIG seeking Task Force volunteer for Plenary Speaker Scheme

Stress-responsive protein’s role in CML revealed

A message from BSH President, Professor Cheng-Hock Toh - June 2019

Myeloma leads the way in cancer survival improvements

Bleeding and thromboembolic risks for blood cancer patients estimated

Immunotherapy hope for paediatric ALL treatment

Dasatinib ‘pauses’ CAR T cell therapy activity

Depression linked to early death in blood cancer patients

Down's syndrome leukaemia genes pinpointed

Rise predicted in B-cell non-Hodgkin’s lymphoma cases

CAR-T cell therapy ‘super-charged’ for solid tumours

Cure Leukaemia Announce 12 Funded Centres Across The UK

Rise expected in haemophilia A and B market

Leukaemia stem cell study reveals cause of immune evasion

Effects of iron status on health studied

Physician Associate Focus - Meet BSH Member Jamie Saunders

BRCA2 mutations linked to childhood lymphoma

A message from BSH President, Professor Cheng-Hock Toh - July 2019

Antibiotics could be used to treat CTCL

New drug target identified for primary effusion lymphoma

Combination therapy shows early success in CLL trial

BSH/NHSE Acute Oncology Services Survey

Hope for new lymphoma ‘immunotransplant’ therapy approach

Mature AML cells can regain stem cell properties

Combination therapy for treatment-resistant ALL studied

Newly launched Haematology Podcast sees early success

Link between anaemia and necrotising enterocolitis studied

Guidelines Session ASM videos available for viewing

BSH seeks Consultant to join Communications Committee

New gene editing technique tested in lymphoma cells

Global Haematology SIG London Workshop

BSH seeks volunteer Chair for Genomics Working Group

NIHR-BSH Researcher of the Year Award

Access to haemophilia drug emicizumab widened

A message from BSH President, Professor Cheng-Hock Toh - August 2019

BSH Rebuttal to NICE NG89 Recommendations

Selinexor shows promise for refractory multiple myeloma

Red blood cell line may revolutionise malaria research

AML drug may be key to cancer immunotherapy

Heart risk after childhood cancer studied

New guidelines on rare aggressive T-PLL

Concern about blood cancer diagnosis progress

Use of haematopoietic stem cell transplantation for sickle cell disease for adults.

NHS England Evidence review: Comments needed on for delayed haemolytic transfusion reactions and hyperhaemolysis in patients with haemoglobinopathies

Three times more men with haemophilia than previously thought

Genomics Focus: Meet Dr Suthesh Sivapalaratnam

New potential targets for lymphoma treatment discovered

Radiotherapy could help prevent CAR-T cell therapy side effects

Scientists discover how lymphoma cells metastasise to the CNS

Arthritis drug could reduce MPN symptoms

Gene test reveals new option for JMML

A message from BSH President, Professor Cheng-Hock Toh - September 2019

Familial risk of blood cancers analysed

BSH Global Haematology SIG: We are looking for a Lab Scientist and Paediatric Haematologist for one week trip to Zambia

Laser technology cuts blood incubation time

Few sickle cell trials cross borders

New combination treatment suggested for AML

Hypertension warning for ibrutinib

Research starts on preventing cognitive decline in paediatric ALL patients

Debate rages over human germline editing

Studies highlight RNA splicing faults in cancer formation

Viagra potential for bone marrow mobilisation

Charity calls for an end to delays in blood cancer diagnosis

Collaboration to boost care of childhood cancer in developing world

Professor Andrew M. Evens appointed as Editor-in-Chief of British Society for Haematology (BSH)’s new Open Access journal eJHaem

Link between cognitive problems and fitness for ALL survivors

Improvements to cancer immunotherapy unveiled

Plant compound could improve gene therapy

‘Prime editing’ system could efficiently correct DNA in human cells

A message from BSH President, Professor Cheng-Hock Toh - October 2019

Board of Trustee Nominations

Hospital visit patterns could identify potential myeloma risk

Treating ‘smouldering’ multiple myeloma delays progression

Trial reduces central nervous system relapse in ALL

New wave of embryonic haematopoiesis discovered

Antibiotics could overcome venetoclax resistance in AML

CRISPR-edited immune cells for cancer tested in Phase I trial

ASH-BSH Abstract Achievement Award winners announced

BSH President's November message

Immunotherapy study identifies multiple myeloma neoantigens

Hydroxyurea may prevent cytarabine resistance in AML

Bone marrow transplant survival rate rises

Progress for Philadelphia chromosome ALL treatment

Join the Teenage and Young Adult Special Interest Group

A look at the complexities and challenges in Lymphoma and the work of the BSH Lymphoma SIG on World Cancer Day Feb 4th 2020

Cutaneous T-cell lymphoma origins revealed

Defect drives primary resistance to CAR-T cell therapy

Gene therapy success for X-CGD patients

International Day of Women & Girls in Science 2020: An Interview with Professor Adele Fielding

Single gene cluster loss associated with multiple myeloma

Aplastic Anaemia Awareness Day 2020

Blood Clot Awareness Month 2020: Blood Clot Management at University Hospitals Plymouth

International Women’s Day 2020 – Interview with Dr. Tamara Everington

COVID-19 Updates

BSH cancels 2020 Annual Scientific Meeting

Charity issues coronavirus guidance for blood cancer patients

Genes identify ‘ultra-high risk’ multiple myeloma

BSH and COVID-19

NIHR Appoints Dr Dan Hart as National Specialty Lead for Haematology

Professor Toh's 24th and final message to BSH: #bettertogether

Announcement of new trustees

Introducing Professor Adele Fielding - BSH Presidents first message

COVID 19 causes new clotting disorder – Dublin study

NHSBT - Understanding the convalescent plasma trials for COVID-19

A message from BSH President, Professor Adele Fielding - May 2020

Novel AML model offers new target

Child shielding rules relaxed - but not for some blood cancer patients

Obituary - Professor Dennis Wright

Trial results support use of early prophylaxis for childhood haemophilia A

A message from BSH President, Professor Adele Fielding - June 2020

Immune landscape of haematological cancers mapped

A message from BSH President, Professor Adele Fielding - July 2020

BSH Member Research – we need your help

A message from BSH President, Professor Adele Fielding - August 2020

Medical marijuana for sickle cell patients means fewer hospitalisations

Guidelines on the use of irradiated blood components published on 18 August 2020

Blood transfusions could protect brain after stroke

A message from BSH President, Professor Adele Fielding - September 2020

Leukaemia nervous system “sanctuary” discovered

What is a virtual poster walk?

A message from BSH President, Professor Adele Fielding - October 2020

Blood group linked to COVID-19 risk

India trial finds limited effectiveness from convalescent plasma

New way to test drugs for children’s cancers

BSH Crucible Prize: Interview with 2020 winner Dr Joshua Bomsztyk

Board of Trustee Nominations 2020

A message from BSH President, Professor Adele Fielding - November 2020

Transplant proves beneficial for older myelodysplastic syndrome patients

No increased COVID-19 risk for children with cancer

COVID-19 thrombosis clarity to improve research

A message from BSH President, Professor Adele Fielding - December 2020

Myeloproliferative neoplasm mutations can occur decades before cancer develops

No benefit from increased haemoglobin threshold for very premature babies

Cord stem cell hope for severe COVID-19

On-off 'switches' to control CAR-T cell activity

Variation in cancer patient COVID-19 responses

New global clinical guidelines for von Willebrand Disease

Scientists identify possible therapeutic approach to overcome AML drug resistance

COVID-19 convalescent plasma collection halted after fresh setback

A message from BSH President, Professor Adele Fielding - January 2021

A message from BSH President, Professor Adele Fielding - February 2021

A message from BSH President, Professor Adele Fielding - March 2021

Cancer patients may need rapid COVID-19 vaccine booster, early study suggests

Single-cell genetic testing method identifies cancer stem cells

Whole genome sequencing role in guiding blood cancer treatment

Mechanism shared by sickle cell disease and malaria resistance revealed

Guidance produced by the Expert Haematology Panel (EHP) focussed on Vaccine induced Thrombosis and Thrombocytopenia (VITT)

Promising dual CAR-T therapy for B-cell lymphoma

New group launched to fund research into Covid-19 vaccine efficacy for blood cancer

A message from BSH President, Professor Adele Fielding - April 2021

Group of charities announce first blood cancer vaccine efficacy research funding

Charity collaborative announces investment of £800K in vaccine efficacy research

Keeping patients with leukaemia safe during the pandemic

Lockdown ending poses multiple risks for blood cancer patients

In memoriam Professor Amit Patel

BSH Board of Trustee elections are now open

BSH supports Strengthening workforce planning in the health and care bill: coalition principles

Election results 2022

BSH's response to the conflict in Ukraine

Study reveals new insights into lethal infant leukaemia

BSH Crucible Prize: Interview with 2022 winner Dr Richard Buka

New target and potential treatment for AML identified

BSH Presidential Message May 2022

Extra sex chromosomes increase clot risk in men

Blood clotting proteins linked to poor breast cancer outcomes

COVID vaccine boosters benefit blood cancer patients

New method to predict hyperdiploid B-ALL relapse risk

Metabolic profile identified in some AML patients

Second COVID booster advised for immunocompromised groups

ProMMise trial launched for relapsed myeloma

Mutations in healthy B-cells similar to cancerous ones

BSH is saddened by the death of Her Majesty, Queen Elizabeth II.

BSH response to the release of the AoMRC new report Fixing the NHS Why we must stop normalising the unacceptable

Update to Oral Anticoagulation Information and Monitoring Booklets (the “Yellow Book”)

Genetic model can predict immune response in sepsis and COVID-19

Antibiotics reduce stomach bleeding risk from aspirin use

New ‘genomic subgroups’ of CLL defined

Lab-grown blood trial aims to reduce transfusions

CAR T-cell therapy success similar for all socioeconomic groups

New role for blood clotting protein discovered

Sickle cell report highlights continuing health inequalities

Asciminib approved for drug-resistant CML in Scotland

Bone marrow organoid breakthrough for blood cancer research

November Message from BSH President - Dr Josh Wright

Extending anticoagulation drug use reduces further DVT clot risk

CAR-T therapy shows promise for CLL, but patients are yet to benefit

Salvage therapy hope after CAR T relapse for multiple myeloma

BSH Board of Trustee Nominations 2023

In memoriam Professor Daniel Catovsky

Blood thinner “ineffective” for severe COVID-19

Leukaemia-related gene mutations may trigger autoimmunity

Trial tests stem cell transplants with multiple sclerosis patients

255 DLBCL therapeutics in clinical trials, global analysis reveals

‘Unexpected’ findings challenge cancer care and improve quality of life

Success after world-first use of base-edited CAR T cell therapy

Re-treatment with CAR-T therapy in NHL ‘is safe’

New ALL treatment protocol ‘promising’

Genetic evolution of Richter’s transformation mapped

December Message from BSH President - Dr Josh Wright

Promising results for novel multiple myeloma drug

Tool stratifies cancer risk for people with clonal haematopoiesis

Blood cancer patients’ strong response to COVID-19 vaccine

Pharmacogenomics of childhood leukaemia published

Women with diabetes face increased risk of venous thromboembolism

RCN INDUSTRIAL ACTION IMPACT ON BLOOD SUPPLY - ENGLAND

Peptide improves anti-clotting properties of heparin

Study clarifies cancer risk from fatigue and other vague symptoms

T-cell therapy for post-transplant viral infections tested

Twin studies reveal new insights into development of childhood leukaemia

Blood Cancer UK appoints new leader as charity sets out awareness priorities

New antibody approach to resistant T cell leukaemia

January Message from BSH President - Dr Josh Wright

The use of reduced-dose apheresis platelet components in a severe shortage situation. 25.01.2023

CAR-T therapy approved for aggressive lymphoma

Timing of chemotherapy may affect outcome for women with DLBCL

Blood thinners underused after minor stroke or TIA

Analysis of acute lymphocytic leukaemia market released

Sickle cell patients report "poor" hospital experiences

New blood product could save lives of trauma patients

Improved gene sequencing for blood cancer diagnosis

Discovery may improve T cell immunotherapies

AI study to help understand fatigue in myeloma

Update on Blood and Platelet supplies

New insights into mechanism of Hodgkin’s lymphoma

Restoration of T cells after stem cell transplant explored

Heartbreak and hope as infant cured of genetic disease

February Message from BSH President - Dr Josh Wright

Update on supply of blood and platelets 27/02/2023:

National Clinical Impact Awards – Role of Member Organisations

“Milestones” in treatments for haemophilia

Convalescent plasma effective as COVID outpatient treatment

Drug could treat resistant AML subtypes

Rare Diseases Action Plan published in England

Vitamin B5 could help patients with myelodysplastic syndrome

Treatment hope for bone marrow failure syndrome

Mixed findings for COVID anticoagulant treatment

NHS cell and gene therapy “factory” opens

First volunteers receive lab grown red cells

Malfunctioning immune cells linked to long COVID

Hope for KMT2A-rearranged or NPM1-mutated acute leukaemia

New hope for improving oxygen delivery disorders

Role of RUNX1 in Down’s syndrome leukaemia investigated

Regulation of RNA splicing could transform blood stem cells

March Message from BSH President - Dr Josh Wright

Blood cancer patients’ positive immune response to COVID vaccine

CAR-T cell therapy improves quality of life

siRNA reduces bleeds in haemophilia A and B patients with or without inhibitors

BSH: Statement on Infected Blood Inquiry, Second Interim Report

Immunotherapy benefits patients with lymphomatoid granulomatosis

New role for lipid metabolism enzyme found in AML

T cells can regulate blood pressure and vascular inflammation in humans

Combination therapy could benefit children with KMT2A-rearranged leukaemias

Hibernating bears offer clot prevention clues

Sex of blood donor does not impact recipient survival

Accurate leukaemia cells generated for research

Medication could boost stem cell mobilisation for myeloma transplants

Pushing the boundaries at the 2023 BSH ASM

Azacitidine improves treatment response in peripheral T-cell lymphomas

Exercise mobilises immune cells in lymphoma patients

Role of mast cells in chronic myeloid leukaemia revealed

Rapid action needed to combat maternal anaemia – WHO

New study to detect CNS involvement of lymphoma

Trial to investigate cancer drug for sickle cell patients

Combination therapy hope for chronic lymphocytic leukaemia

Blood genotyping first for sickle cell disease and thalassaemia

Drug ends blood transfusion dependency for many with MDS

Popular anti-arrhythmic drug brings bleeding risk

May Message from BSH President - Dr Josh Wright

Analysis reveals outcomes of pregnant women with lymphoma

Early promise for multi-cancer blood test

New approach to HSC expansion in the lab

Multi-million-pound investment in engineering models of leukaemia

Ibrutinib and venetoclax effective for high-risk CLL

CAR-T as second-line therapy improve survival in B-cell lymphoma

BSH Crucible Prize: Interview with 2023 winner Dr Peter Johnstone

More hope for CAR-T therapy for paediatric T cell leukaemia

Sickle cell toll growing, experts warn

June Message from BSH President - Dr Josh Wright

New rare blood disease identified

Astronauts experience altered gene expression in white blood cells

24/7 crisis centres promised for sickle cell day

Haematologists honoured

BSH Statement on Government Workforce Plan

Antibody treatment prevents graft versus host disease

Embryo gene editing warning, conference hears

UK plasma can now be used to manufacture albumin treatments

New gene editing technique could benefit sickle cell and thalassaemia patients

Real-world COVID-19 vaccine response in high-risk patients

Genetic signature of CAR-T cells could hold key to children’s leukaemia remission

Obesity poses risk for leukaemia patients under 50

Raised COVID risk for blood type A explained

Data gathering for better blood and organ matching begins

Virus-free CAR-T therapy for multiple myeloma developed

Survival rising for children with acute leukaemia

July 2023 Message from BSH President - Dr Josh Wright

African malaria adaptation responsible for low white cell counts

Progress on umbilical cord cells against cancer

Women and children disproportionately affected by anaemia globally

Cancer patients remain at raised risk from COVID

Fertility may decline earlier in women treated for Hodgkin’s lymphoma

Myelodysplastic syndrome frequently misdiagnosed, study finds

Lymphoma patients benefit from COVID booster vaccines

New treatment hope for fusion-driven cancer

Study identifies those least likely to have COVID-19 antibodies

Study finds AL amyloidosis outcome predictors

New diabetes drug could treat chronic myeloid leukaemia

Role of TET2 mutations in AML explained

Novel drug in development for heparin side effect

August 2023 Message from BSH President - Dr Josh Wright

Aspirin still needed after stent insertion

Blood clots clue to ‘long-COVID’ cognitive issues

Mechanisms of multiple myeloma therapy resistance identified

Promising stem cell treatment for sickle cell disease

Insights into leukaemia drug target revealed

Vitamins could limit complications in acute myeloid leukaemia

VTE risk when painkillers used alongside hormonal contraception

Preparations for blood group genotyping for people with sickle cell, thalassemia and rare anaemia

Discovery brings new hope for improved myeloma treatments

Auto-antibodies may trigger thrombosis risk in COVID-19

Brain bleed risk factor may be transmissible through transfusion

Bariatric surgery may reduce haematological cancer risk in women

Thromboembolism risk from multiple factors assessed

Cancer conference centres on haematological cancers

BSH statement on Physician Associates and related roles

September 2023 Message from BSH President - Dr Josh Wright

New treatment option for adult multiple myeloma

DVT ultrasounds in emergency departments could reduce overcrowding

New paediatric bone marrow transplant service in East Anglia

New Sickle Cell Initiative in Zambia

Effect of diabetes on multiple myeloma varies by race

New potential T cell therapy for acute myeloid leukaemia

Stem cell therapy effective for multiple sclerosis

Drug helps hard-to-treat multiple myeloma

Venous thrombosis prediction model confirmed in large-scale trial

Backing for powerful new lymphoma drug

Multiple myeloma research unit launches

Model replicates MLL-AF4 sub-type of ALL

CAR T-cell therapy for myeloma effective for different ethnic groups

Clear role of genetics in blood clot risk on the pill

Advanced therapies for pulmonary embolism compared

Sepsis care failings “incredibly disheartening”

October 2023 Message from BSH President - Dr Josh Wright

Gene therapy trial for Hunter’s syndrome to begin

Sickle cell disease patients open to gene therapy

Mechanism of clotting risk from vaccines examined

Re-engineering CARs may improve blood cancer therapy

Gene mutation ‘barcodes’ give clues to clonal haematopoiesis

Novel gene therapy for combined immunodeficiency

Applications open for BSH Fellows in Clinical AI

MHRA approve the use of gene editing therapy in sickle cell disease and transfusion dependent thalassaemia

Gene editing treatment backed for sickle cell and thalassaemia

Novel gene test to guide acute myeloid leukaemia therapy

Liberal blood transfusions might help heart attack patients with anaemia

November 2023 Message from BSH President - Dr Josh Wright

Shortage of sickle cell nurses putting patients at risk

Insight into cell mutations after sickle cell gene therapy

New method to classify paediatric ALL

Iron infusion before bowel surgery reduces blood transfusion risk

Adult thalassaemia stem cell transplants approved in England

Faster sterility testing of T-cell therapies

Possible RNA target for AML therapy

BSH Board of Trustee Nominations 2024

Role of NPM1 gene variant in leukeamia revealed

End of blood donor discrimination posed no safety risk

December 2023 Message from BSH President - Dr Josh Wright

Treatment advances benefitting AML patients, ASH hears

UK reports major CLL breakthrough

Circulating tumour DNA holds key to Hodgkin’s lymphoma prognosis

Novel CAR T therapy shows promise for lymphoma

Backing for new treatment for chronic graft versus host disease

Mutations study offers hope for myelodysplastic syndromes patients

New blood platelet tool easier and more precise

New hope of eradicating aggressive form of AML

CD20-directed immunotherapy resistance partially explained

Risk of blood clots falls rapidly after stopping hormonal contraceptives

Common beta blocker to be trialled for sickle cell cardiomyopathy

Prophylactic treatment may prevent myeloma immunotherapy side effects

Age affects diagnosis of von Willebrand disease

Gut bacteria combination could protect stem cell transplantation patients

Key regulator of blood stem cell fate identified

Individual risk prediction model for multiple myeloma unveiled

Obesity linked to blood cancer precursor MGUS

Young sickle cell patients less likely to have COVID-19 vaccines

January 2024 Message from BSH President - Dr Josh Wright

Hepatitis may trigger a treatable myeloma, researchers report

NHS to offer blood group genotype test for transfusion patients

Promising results for CAR-NK cells for B-cell cancers

AI recognises mutations from AML bone marrow images

Inherited genetic variants’ role in MPNs

RNA sequencing 'promising' for B-ALL paediatric patients

Children’s cancer taskforce launched

Lipid-based classification of AML resistance risk

Finding the best hypertension treatment for patients taking BTKi

Genetic study of anticoagulant side-effects

Hope for CRISPR technique for FHL

New breakthrough in leukaemia-HIV double treatment case

Call for action on ‘blood deserts’

Hope for STAb-T cell therapy for myeloma

Proteins identified that help lymphoma hide

February 2024 Message from BSH President - Dr Josh Wright

Designer antibody could boost AML treatment

NHS approves new GvHD drug

Skeleton clues to ancient anaemia prevalence

Wide-ranging European guidance on adult ALL published

Molecular profile of rare leukaemia revealed

Hodgkin’s survivors omitted from high-risk breast checks

AI shows lymphoma detection promise

Cancer frequency among CAR-T adverse events

Blood sample requests increase later willingness to donate stem cells

Stem cell transplant outcomes improving among over 65s

Blood production may vary across skeleton

New SCID mutation identified

March 2024 Message from BSH President - Dr Josh Wright

Methylation profiling predicts myelodysplastic syndrome treatment response

Changes that trigger aggressive follicular lymphoma identified

Can some CLL patients live without specialist follow-up?

Ancient ALL risk gene in Hispanic and Latino groups identified

Familial Alzheimer’s disease transferred in mouse stem cell transplant

TP53 mutations in AML increase CAR-T resistance

Hope for overcoming AML treatment resistance

Precision medicine improves care of relapsed paediatric cancers

Synthetic platelets stop bleeding and enhance healing

Innovative study to reduce AML treatment side effects

PHD inhibitors offer hope for AML treatment

New hope for hypertensive treatment for sickle cell

April 2024 Message from BSH President - Dr Josh Wright

Brain study may aid care of sickle cell pain crises

Campaigners urge government to prioritise leukaemia research

Trial results for gene therapy for sickle cell and thalassaemia published

Thank you to Dr Josh Wright, BSH President, 2022-2024

Coin-sized device could transform blood diagnostics

Novel treatment developed for T-cell leukaemias and lymphomas

Survivorship portal for paediatric cancer launched

“Decisive step forward” in creation of universal donor blood

Plan to improve myeloma diagnosis

U-turn as NHS offers new sickle cell drug

AML treatment assessed for over-80s

New clonal haematopoiesis genes found

Proposal for new immune checkpoint target

BSH statement on the Infected Blood Inquiry

BSH Crucible Prize: Interview with 2024 winner Dr Lisa Jeffers

BSH Lifetime Achievement Award 2024

Hope for “gentler” stem cell transplants

Infected blood inquiry backs peer review and calls for extra patient voice

Exercise may improve rituximab treatment for CLL

Welcome to new President, Dr Sue Pavord

May 2024 Message from BSH President - Dr Sue Pavord

Ageing linked to “short cut” hyperreactive platelets

Scientists find mutations underlying childhood immune disorders

Possible tattoo link to lymphoma

Challenge to reduce bleeding risk from low-dose direct oral anticoagulants

Childhood AML tracked to foetal chromosomal changes

Role of neutrophils in CAR-T complication studied

New approach to reducing stem cell treatment distress

Pseudo lymph node might improve CAR-T

Lung microbiomes predict risk to child stem cell recipients

Hopeful results from sickle gene editing

Immune suppressant supercharges Hodgkin’s treatment

Leukaemia T cells age centuries in one life-time

June 2024 Message from BSH President - Dr Sue Pavord

Charity raise alarm as myeloma combination faces loss of approval

Ageing in HSCs linked to declining growth factor levels

Testing for IgG reduces infection risk for blood cancer patients

Gene-protein study points to opportunities to improve myeloma treatment

Step forward for engineered plasma cell therapy

Whole genome sequencing improving paediatric care in England

Bacteriophage as GvHD treatment?

Platelet discoveries point to immune role

Tailored drug may combat drug-resistant AML

Donor background affects stem cell transplant success

Pregnancy hope after stem cell transplant

Some blood cancer patients suffer from growing NHS delays

NHS blood transfusion strategy development begins

Hydroxyurea does not affect ovarian reserve in female SCD patients

Blinatumomab improves MRD-negative ALL survival

July 2024 Message from BSH President - Dr Sue Pavord

Toxicity monitoring period for CAR-T could be reduced, study suggests

Immune cell offers hope for preventing GvHD

Iron metabolism offers target for improving AML care

Discovery points to improving stem cell harvesting

England approves beta-thalassaemia gene therapy

New targets for preventing infant ALL drug resistance

Macrophage ‘appetiser’ could improve immunotherapy

Genetic variations may predict relapse risk in childhood ALL

World’s men face increasing risk from blood cancers

Genetic target for treatment of stress-induced blood disorders

P-bodies offer hope for AML treatments

UK project to find genetic profile of best cell donors

August 2024 Message from BSH President - Dr Sue Pavord

Hope for new treatment for infant leukaemia

Low-intensity transplants may benefit sickle cell patient lungs

Trial of drone transport for blood products

Call to improve UK blood cancer survival

HIV patient achieves remission by transplant without protective mutation

Lab-developed blood stem cell success in Australia

National Non-Hodgkin Lymphoma Audit (NNHLA) - State of the Nation Report published

Risk of second cancers after CAR-T assessed

Scotland gains two new myeloma treatments

Sickle cell trait link to blood clots examined

Bleeding risks studied in cancer patients

New blood group solves half a century of mystery

Pomalidomide successfully treats bleeding disorder

September 2024 Message from BSH President - Dr Sue Pavord

Genetic analysis points to low intensity treatments for some B-cell ALL patients

NHS offers new oral drug for acute myeloid leukaemia

Type 2 immune response may boost CAR-T

The annual John Dacie Lecture at the 65th BSH Annual Scientific Meeting

National Pathology Week Webinars 2024

JAK inhibitor shows promise for CML

Neonate screening begins for rare diseases

Warning over sickle cell stroke risk

Epigenetic finding may improve myeloma immunotherapy

Multimillion dollar project to discover mysteries of the marrow

Young women invited to be stem cell donors

SHOT is pleased to announce the appointment of Dr Megan Rowley as the new Chair of the SHOT Steering Group

Cancer survivors to help in AI study of immune response

Improved humanised mice could boost immunotherapy research

New CAR-T offers hope for T-ALL

Welcome as myeloma antibody extended to benefit more patients

October 2024 Message from BSH President - Dr Sue Pavord

Precision medicine project seeks treatments for myeloid disease

Subset of stem cells control ageing of immune system

TET2 mutation findings open the way to therapies

Features identified that might predict CAR-T success

New concessions in England on myeloma treatment

Stem cells studied decades after transplant

AI on the way for bone marrow cell counts

Multimillion-pound project to develop blood stem cell production

NHS changes rules following interferon shortage

NHS Fellowship in Clinical AI

Chinese haematologists study COVID vaccine side effect

Hope for Diamond-Blackfan gene therapy

Myeloma microenvironment atlas unveiled

Welcome to the new Editors of the British Journal of Haematology & eJHaem

New role for glutamine in red blood cells discovered

NSAIDs boost anticoagulant bleeding risk

Tropical virus warning system introduced for UK blood supplies

November 2024 Message from BSH President - Dr Sue Pavord

CRISPR trial for sickle cell announced

Impact of checkpoint inhibitors on immune system

Innovative therapy developed for diffuse large B cell lymphoma

Antibody shows promise as haemophilia treatment

JAK inhibitor tested for graft v host disease

Second generation CAR-T shows promise for ALL

December 2024 Message from BSH President - Dr Sue Pavord

Honours for haematologists

Improved CAR-NK cell immunotherapy for AML

Success for technique to test banked blood cells

Backing for reduced dose oral anticoagulants

Link between mutation and clonal haematopoiesis revealed

New guidance on blood cancer during pregnancy

Natural killer cell immunotherapy shows promise

Novel breast cancer drug offers hope for myeloid cancers

Persistent DNA damage offers clue to blood cancer causes

Enter The Royal College of Pathologists’ Foundation Essay Prize

Committee & SIG Highlights 2024

Hepatitis B risk during immunosuppressive treatment

Sickle cell impact on the brain studied

‘Sprinters’ and ‘marathon runners’ in CAR T treatment

January 2025 Message from BSH President - Dr Sue Pavord

Obituary – Professor Eric Preston (1935-2025)

Developmental changes linked to lifetime cancer risk in mice

How COVID boosters helped blood cancer patients

UK approval for gene therapy for severe sickle cell disease

Myeloma survivorship project under way

Progress in asparaginase improvement

Sickle cell trait should not be listed as a cause of death – ASH

Case study of patient acquiring new cancer after transplant

New blood clotting disorder described

Myeloma ‘break-out’ lesions in the bone investigated

Call for early genetic testing for myeloma patients

New CAR-T approved for lymphoma in England

Studies back anticoagulant treatment for elderly

February 2025 Message from BSH President - Dr Sue Pavord

Detailed study of lymphoma acquired from CAR-T therapy

Major UK trial to test benefits of concentrated plasma for heart surgery complications

Blinatumomab gains backing for MRD-negative ALL

Researchers ready to test malaria drug for blood cancers

Backing for efanesoctocog alfa in England for haemophilia

UK-sourced plasma back in use in NHS

New therapy is ALA CART for resistant disease

NICE approves treatment for rare immune disorder

X-SCID gene therapy tested in China

One year on - a blog by BSH CEO Carol Bewick

AI recognition of cell shape could revolutionise drug development

Congenital heart disease link to childhood cancer

Exportin-1 research could open way for new treatments

blood donation for haemochromatosis

BSH supports the Haematology Patients & Carers Congress (HPCC 2025)

March 2025 Message from BSH President - Dr Sue Pavord

New technique to improve adult stem cell harvest

New candidates for sickle cell gene therapy identified

Genetic benefits from frequent blood donation revealed